Is the gold rush in immunotherapy trials good? – MedCity News
MedCity News |
Is the gold rush in immunotherapy trials good?
MedCity News Although the concept of immunotherapy has been around for more than a century, it only gained prominence as a method of targeted cancer therapy in the early 2000s. In 2015, Merck’s Keytruda® (pembrolizumab), a checkpoint inhibitor drug, made … |
The Hindu |
Stem cell therapy gets Rajasthan boy back on feet
The Hindu The thought that he would have to be dependent on others for the rest of his life was killing us, until I read about Dr. Pradeep Mahajan and stem cell therapy,” Rohit’s mother Pooja Gehlot said. A relative of the Gehlot family, who lives in Navi Mumbai … Eight-year-old paraplegic boy gets back on feet, regains sensory perception after cell-based therapy in Mumbai clinicUnited News of India |